Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Hims & Hers Health Inc shares valued at $3,214,881 were purchased by Carroll Patrick Harrison on Aug 06 ’25. At $53.58 per share, Carroll Patrick Harrison acquired 60,000 shares.
Also, Chi Michael sold 26,350 shares, netting a total of over 1,765,450 in proceeds. Following the sale of shares at $67.00 each, the insider now holds 278,654 shares.
Before that, Chi Michael had sold 250 shares from its account. In a trade valued at $16,110, the Chief Commercial Officer traded Hims & Hers Health Inc shares for $64.44 each. Upon closing the transaction, the insider’s holdings decreased to 250 shares, worth approximately $14.23 million.
As published in a research note from Needham on June 23, 2025, Hims & Hers Health Inc [HIMS] has been rated down from a Buy to a Hold. Analysts at Needham resumed the stock at ‘”a Buy”‘ outlook in a report released in early June. As of April 29, 2025, TD Cowen has decreased its “Buy” rating to a “Hold” for HIMS. Earlier on February 18, 2025, Morgan Stanley downgraded its rating. Their new recommendation was “an Equal-weight” for HIMS stock which previously was a “an Overweight”.
Analyzing HIMS Stock Performance
On last trading session, Hims & Hers Health Inc [NYSE: HIMS] plunged -0.16% to $51.05. The stock’s lowest price that day was $50.25, but it reached a high of $53.53 in the same session. During the last five days, there has been a drop of approximately -22.86%. Over the course of the year, Hims & Hers Health Inc shares have jumped approximately 186.15%.
Is Hims & Hers Health Inc subject to short interest?
Stocks of Hims & Hers Health Inc saw a sharp rise in short interest on 2025-07-15 jumping by 3.6 million shares to 65.3 million. Data from Yahoo Finance shows that the short interest on 2025-06-13 was 61.69 million shares. A jump of 5.52% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 1.42 of the overall float, the days-to-cover ratio (short ratio) jumped to 1.42.
Which companies own the most shares of Hims & Hers Health Inc (HIMS)?
In terms of Hims & Hers Health Inc share price expectations, FactSet research, analysts set an average price target of 55 in the next 12 months, up nearly 7.57% from the previous closing price of $51.13. Analysts anticipate Hims & Hers Health Inc stock to reach 68 by 2025, with the lowest price target being 30. In spite of this, 13 analysts ranked Hims & Hers Health Inc stock as Buy at the end of 2025. On January 10, 2025, Citigroup assigned a price target of “a Sell” to the stock and downgraded coverage with a $25.
